L-Ornithine Derived Polyamines in Cystic Fibrosis Airways
Increased arginase activity contributes to airway nitric oxide (NO) deficiency in cystic fibrosis (CF). Whether down-stream products of arginase activity contribute to CF lung disease is currently unknown. The objective of this study was to test whether L-ornithine derived polyamines are present in...
Main Authors: | Grasemann, Hartmut, Shehnaz, Darakhshanda, Enomoto, Masahiro, Leadley, Michael, Belik, Jaques, Ratjen, Felix |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465344/ |
Similar Items
-
Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis
by: Grasemann, Hartmut, et al.
Published: (2006) -
New Developments in Cystic Fibrosis Airway Inflammation
by: Palaniyar, Nades, et al.
Published: (2015) -
Characterization of the Link between Ornithine, Arginine, Polyamine and Siderophore Metabolism in Aspergillus fumigatus
by: Beckmann, Nicola, et al.
Published: (2013) -
Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
by: Bergin, David A, et al.
Published: (2013) -
Effect of Arginase Inhibition on Pulmonary L-Arginine Metabolism in Murine Pseudomonas Pneumonia
by: Mehl, Anne, et al.
Published: (2014)